3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
poly ICLC
1
copanlisib
1
avelumab
1
Yoga
1
Immunoglobulins, Intravenous
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Celecoxib
1
Aromatherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
FED
×
Immunoglobulins, Intravenous
×
Clear all
NCT06064279
2024-09-19
HAITEN-ICI
VA Office of Research and Development
Phase 1/2
Withdrawn